Neurogene

(NASDAQ) NGNE

Current Price$32.59

Market Cap$451.92M

Since IPO (2023)+92%

5 Year-87%

1 Year+92%

1 Month+40%

Neurogene Financials at a Glance

Market Cap

$451.92M

Revenue (TTM)

$0.00

Net Income (TTM)

$90.35M

EPS (TTM)

$-4.71

P/E Ratio

-6.14

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$32.59

Volume

15,595

Open

$29.28

Price

$32.59

Volume

15,595

Open

$29.28

Previous Close

$32.59

Daily Range

$29.28 - $33.00

52-Week Range

$12.97 - $37.27

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$32.59

Volume

15,595

Open

$29.28

Previous Close

$32.59

Daily Range

$29.28 - $33.00

52-Week Range

$12.97 - $37.27

NGNE News

No articles available.

NGNE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neurogene

Industry

Biotechnology

Sector

Health Care

Employees

131

CEO

Rachel L. McMinn, PhD

Website

www.neurogene.com

Headquarters

New York City, NY 10011, US

NGNE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-31%

Return on Capital

-38%

Return on Assets

-31%

Earnings Yield

-16.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$451.92M

Shares Outstanding

15.62M

Volume

15.60K

Avg. Volume

174.59K

Financials (TTM)

Gross Profit

$3.19M

Operating Income

$103.21M

EBITDA

$103.33M

Operating Cash Flow

$77.17M

Capital Expenditure

$1.18M

Free Cash Flow

$78.36M

Cash & ST Invst.

$269.01M

Total Debt

$9.89M

Neurogene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$787.00K

+94.9%

Gross Margin

0.00%

N/A

Market Cap

$451.92M

N/A

Market Cap/Employee

$4.22M

N/A

Employees

107

N/A

Net Income

$24.73M

-26.8%

EBITDA

$26.74M

-29.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$259.12M

-13.6%

Accounts Receivable

$460.00K

-29.0%

Inventory

$0.00

N/A

Long Term Debt

$6.83M

-27.6%

Short Term Debt

$3.06M

+2.2%

Return on Assets

-31.24%

N/A

Return on Invested Capital

-37.88%

N/A

Free Cash Flow

$16.79M

+4.7%

Operating Cash Flow

$16.67M

+4.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.70+3.66%

PRTCPureTech Health plc

PRTCPureTech Health plc$17.01+1.89%

ADCTADC Therapeutics S.A.

ADCTADC Therapeutics S.A.$3.86+2.66%

OCGNOcugen, Inc.

OCGNOcugen, Inc.$1.46-2.35%

FULCFulcrum Therapeutics, Inc.

FULCFulcrum Therapeutics, Inc.$7.11+1.28%

SLDBSolid Biosciences Inc.

SLDBSolid Biosciences Inc.$7.20+4.35%

BNTCBenitec Biopharma Inc.

BNTCBenitec Biopharma Inc.$12.57+3.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

CPNGCoupang

CPNGCoupang$17.89-0.14%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

POETPoet Technologies

POETPoet Technologies$9.72+0.06%

Questions About NGNE

What is the current price of Neurogene?

Neurogene is trading at $32.59 per share.

What is the 52-week range for Neurogene?

Over the past 52 weeks, Neurogene has traded between $12.97 and $37.27.

How much debt does Neurogene have?

As of the most recent reporting period, Neurogene reported total debt of $9.89M.

How much cash does Neurogene have on hand?

Neurogene reported $103.84M in cash and cash equivalents in its most recent financial results.

What is Neurogene’s dividend yield?

Neurogene does not currently have a dividend yield.

Neurogene

Neurogene Financials at a Glance

NGNE News

NGNE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Neurogene

NGNE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Neurogene Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NGNE

What is the current price of Neurogene?

What is the 52-week range for Neurogene?

How much debt does Neurogene have?

How much cash does Neurogene have on hand?

What is Neurogene’s dividend yield?

Premium Investing Services